PASITHEA THERAPEUTICS CORP. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
PASITHEA THERAPEUTICS CORP. (KTTA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 30.72 thousand shares for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2025-11-13
- PASITHEA THERAPEUTICS CORP. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-09-30 was 0.00 shares.
- PASITHEA THERAPEUTICS CORP. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-06-30 was 13.53K shares, a 183.55% increase year-over-year.
- PASITHEA THERAPEUTICS CORP. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-03-31 was 17.19K shares, a 59.81% decline year-over-year.
- PASITHEA THERAPEUTICS CORP. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2024-09-30 was -29.89K shares.
- PASITHEA THERAPEUTICS CORP. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 100.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 13.53K shares derived: sum of 2 quarters · filed 2025-11-13 | 30.72K shares 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 13.53K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 30.72K shares 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | 17.19K shares 10-Q · filed 2025-05-15 | |||
| 2024-09-30 | -29.89K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -25.12K shares derived: sum of 2 quarters · filed 2024-11-13 | 17.65K shares 10-Q · filed 2024-11-13 | |
| 2024-06-30 | 4.77K shares 10-Q · filed 2024-08-13 | 47.54K shares 10-Q · filed 2024-08-13 | ||
| 2024-03-31 | 42.77K shares 10-Q · filed 2024-05-14 | |||
| 2022-12-31 | 100.00K shares 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |